Concepedia

Andreas Wolff

AW

Statistics

Publications

4

Citations

59

H-Index

4

Active since

2022

Affiliations

Technical University of Munich(Current)

German Center for Neurodegenerative Diseases

Klinikum rechts der Isar

Andreas Wolff is an author at Technical University of Munich.

Publications per year

2022–2024

4

Publications

4

SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants

Andreas Wolff, Jörg Peine, Josef Höfler et al. · CNS Drugs · 2024 · 20 citations · Full text

Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)

Andreas Wolff, Helen Bidner, Yvonne Remane et al. · Frontiers in Aging Neuroscience · 2024 · 17 citations · Full text

Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson Disease

Dominik Pürner, Mohammad Ali Hormozi, Daniel Weiß et al. · Neurology · 2023 · 12 citations · Full text

Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease from the Perspective of Treating Physicians—A Nationwide Cross-Sectional Study

Andreas Wolff, Bernhard Haller, Antonia F. Demleitner et al. · Brain Sciences · 2022 · 10 citations · Full text

1–4 of 4